2m 2m 2m 2m 2m 2m 2m
Remedent (REMI)
OTC
$0.0007+$0.0001 (+16.67%)
Price as of Jan 30, 2026- $13,997.00Market Cap
- -98.44%1-Year Change
- Medical Instruments & SuppliesIndustry
Remedent (REMI)
$0.0007+$0.0001 (+16.67%)
REMI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | +$0.0001 (+16.67%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 30,000 | ||
30-Day Average Volume | 30,000 | ||
1-Week Change | 16.67% | ||
1-Month Change | 16.67% | ||
1-Year Change | -98.44% | ||
3-Year Change | -99.59% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 20.0M | ||
Total Assets | $7.6M | ||
Market Cap | $13,997.00 | ||
Enterprise Value | $26,055.00 | ||
Period: QTR TTM FY | |||
Revenue | $337,468.00 | ||
Net Income | $94,456.00 | ||
Free Cash Flow | $68,499.00 | ||
EBIT | $98,238.00 | ||
EBITDA | $106,919.00 | ||
Net Working Capital | -$2.2M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 0 | ||
Price/Operating Cash Flow | 0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||